HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics

More filters

Study design
Intervention type
Study phase
236studies shown
Showing 13-24 of 236
Drug study icon
RecruitingNCT06126224

KarXT or placebo for psychosis linked to Alzheimer’s disease

About this titleRead the official source — NCT06126224
Official study title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

Recruiting in China
SchizophreniaMedication studyAges 55–90
Countries
China, United States, Canada, + 11 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Drug study icon
RecruitingNCT06929273

Long-term safety of KarXT in bipolarity type I

What is this study about?

This extension study evaluates the long-term safety and tolerability of KarXT for mania or mania with mixed features in people living with bipolarity type I.

Recruiting in China
BipolarityMedicationAges 18–65
Countries
China, United States, Australia, + 17 others
Sponsor
Bristol-Myers Squibb (Pharmaceutical company)
Drug study icon
RecruitingNCT06585787

KarXT or placebo for psychosis in Alzheimer’s disease

About this titleRead the official source — NCT06585787
Official study title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

Recruiting in China
SchizophreniaMedication studyAges 55–90
Countries
China, United States, France, + 21 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Drug study icon
RecruitingNCT07140913

KarXT with lithium, valproate, or lamotrigine for mania in bipolarity

About this title

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

Read the official source — NCT07140913
What is this study about?

Researchers compare KarXT with placebo, each added to lithium, valproate or lamotrigine, in people with bipolarity type I experiencing mania, with or without mixed features. They want to know whether adding KarXT improves manic symptoms and assess its safety.

Recruiting in China
BipolarityMedication studyAges 18–65
Countries
China, United States, France, + 10 others
Sponsor
Bristol-Myers Squibb (Pharmaceutical company)
Device study icon
RecruitingNCT07198594

Individualized accelerated magnetic stimulation for OCD symptoms

About this title

Accelerated rTMS Therapeutic Approach for Refractory Obsessive-Compulsive Disorder

Read the official source — NCT07198594
What is this study about?

This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with OCD.

Recruiting in China
OCDInterventional studyAges 18–60
Countries
China
Sponsor
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.